Skip to main content
SpringerLink
Log in

Spasticity Management: Nonoperative and Operative

  • Chapter
  • First Online:
Orthopedic Care of Patients with Cerebral Palsy

  • 675 Accesses

Abstract

Spasticity in patients with cerebral palsy is a common problem and leads to pain and development of orthopedic impairments as a patient ages. There are a multitude of options both surgical and nonsurgical that are currently utilized to help control spasticity in an attempt to prevent the known consequences on growth. This chapter overviews spasticity, how to assess it, and how to manage it through oral medications, local injections, and surgical interventions including intrathecal baclofen and selective dorsal rhizotomy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Van Naarden BK, Doernberg N, Schieve L, et al. Birth prevalence of cerebral palsy: a population-based study. Pediatrics. 2016;137(1):e20152872.

    Google Scholar 

  2. Lance JW. The control of muscle tone, reflexes, and movement: Robert Wartneberg Lecture. Neurology. 1980;30(12):1303–13.

    CAS  PubMed  Google Scholar 

  3. Patrick E, Ada L. The Tardieu scale differentiates contracture from spasticity whereas the Ashworth scale is confounded by it. Clin Rehabil. 2006;20(2):173–82.

    PubMed  Google Scholar 

  4. Knights S, Datoo N, Kawamura A, et al. Further evaluation of the scoring, reli- ability, and validity of the hypertonia assessment tool (HAT). J Child Neurol. 2014;29(4):500.

    PubMed  Google Scholar 

  5. Meseguer-Henarejos AB, Sanchez-Meca J, Lopez-Pina JA, Carles-Hernandez R. Inter- and intra-rater reliability of the Modified Ashworth Scale: a systematic review and meta-analysis. Eur J Phys Rehabil Med. 2018;54(4):576–90.

    PubMed  Google Scholar 

  6. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol. 1999;6:23–35.

    Google Scholar 

  7. Fosang AL, Galea MP, Mccoy AT, Reddihough DS, Story I. Measures of muscle and joint performance in the lower limb of children with cerebral palsy. Dev Med Child Neurol. 2003;45(10):664–70.

    PubMed  Google Scholar 

  8. Banky M, Clark R, Pua Y, Mentiplat B, Olver J, Williams G. Inter- and intra-rater variability of testing velocity when assessing lower limb spasticity. J Rehabil Med. 2019;51:54–60.

    PubMed  Google Scholar 

  9. Nance PW, Young RR. Antispasticity medications. Phys Med Rehabil Clin N Am. 1999;10:337–55.

    CAS  PubMed  Google Scholar 

  10. Young RR, Delaide PJ. Drug therapy: spasticity (second of two parts). N Engl J Med. 1981;304:96–9.

    CAS  PubMed  Google Scholar 

  11. Young RR, Emre M, Nance PW, et al. Current issues in spasticity management. Neurologist. 1997;3:261–75.

    Google Scholar 

  12. Katz RT, Campagnolo DI. Pharmacologic management of spasticity. Phys Med Rehabil State Art Rev. 1994;8:473–80.

    Google Scholar 

  13. Mandac BR, Hurvitz EA, Nelson VS. Hyperthermia associated with baclofen withdrawal and increased spasticity. Arch Phys Med Rehabil. 1993;74:96–7.

    CAS  PubMed  Google Scholar 

  14. He Y, Brunstrom-Hernandez JE, Thio LL, et al. Population pharmacokinetics of oral baclofen in pediatric patients with cerebral palsy. J Pediatr. 2014;164:1181–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Alonso RJ, Mancall EL. The clinical management of spasticity. Semin Neurol. 1991;11:215–9.

    CAS  PubMed  Google Scholar 

  16. Watanabe TK. Role of oral medications in spasticity management. Phys Med Rehabil. 2009;1:839–41.

    Google Scholar 

  17. Nance PW. Tizanidine: an alpha2-agonist imidazoline with anti-spasticity effects. Today’s Ther Trends. 1997;15:11–25.

    Google Scholar 

  18. PDR Tizanidine Dosage and Indications. https://www.pdr.net/drug-summary/Tizanidine-tizanidine-3138.2963. Retrieved March 4, 2019.

  19. Ward A, Chaffman MO, Sorkin EM. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs. 1986;32:130–68.

    CAS  PubMed  Google Scholar 

  20. Young RR, Delaide PJ. Drug therapy: spasticity (first of two parts). N Engl J Med. 1981;304:28–33.

    CAS  PubMed  Google Scholar 

  21. Taketomo CK, et al. Pediatric & neonatal dosage handbook a universal resource for clinicians: treating pediatric and neonatal patients; 2016–2017. 23rd ed. Hudson: Lexi-Comp; 2016.

    Google Scholar 

  22. Sieghart W. Pharmacology of benzodiazepine receptors: an update. J Psychiatry Neurosci. 1994;19:24–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Krach LE. Pharmacotherapy of spasticity: oral medications and intrathecal baclofen. J Child Neurol. 2001;16:31–6.

    CAS  PubMed  Google Scholar 

  24. Verrotti A, Greco R, Spalice A, et al. Pharmacotherapy of spasticity in children with cerebral palsy. Pediatr Neurol. 2006;34:1–6.

    PubMed  Google Scholar 

  25. Whelan MA, Frcpc FM. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2010;75(7):669.

    PubMed  Google Scholar 

  26. Munchau A. Regular review: uses of botulinum toxin injection in medicine today. BMJ. 2000;320(7228):161–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Tilton AH. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders. J Child Neurol. 2003;18(1_suppl):S50–66.

    PubMed  Google Scholar 

  28. Jankovic J. Botulinum toxin: state of the art. Mov Disord. 2017;32(8):1131–8.

    CAS  PubMed  Google Scholar 

  29. Riedel P, Marino MH. Pharmacologic treatment tools: systemic medications and toxins, opportunities, and pitfalls. Phys Med Rehabil Clin N Am. 2018;9(3):501–17.

    Google Scholar 

  30. de Paiva A, Meunier FA, Molgo J, et al. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A. 1999;96:3200–5.

    PubMed  PubMed Central  Google Scholar 

  31. Brin M, Aoki KR. Botulinum toxin type a: pharmacology. In: Mayer N, Simpson DM, editors. Spasticity—etiology, evaluation, management and the role of botulinium toxin. New York: WE MOVE; 2002. p. 110–24.

    Google Scholar 

  32. Borodic GE, Joseph M, Fay L, Cozzolino D, Ferrante RJ. Botulinum a toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck. 1990;12(5):392–9.

    CAS  PubMed  Google Scholar 

  33. Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum a toxin injections. Mov Disord. 1994;9(1):31–9.

    CAS  PubMed  Google Scholar 

  34. Phadke C, Balasubramanian C, Holz A, Davidson C, Ismail F, Boulias C. Adverse clinical effects of botulinum toxin intramuscular injections for spasticity. Can J Neurol Sci. 2016;43(2):298–310.

    PubMed  Google Scholar 

  35. Wohlfarth K, Sycha T, Ranoux D, Naver H, Caird D. Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment? Curr Med Res Opin. 2009;25(7):1573–84.

    CAS  PubMed  Google Scholar 

  36. Francisco GE. Botulinum toxin: dosing and dilution. Am J Phys Med Rehabil. 2004;83(suppl):S30–7.

    PubMed  Google Scholar 

  37. D’Souza RS, Warner NS. Phenol nerve block. [Updated 2019 Feb 28]. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2019. Available from: https://www-ncbi-nlm-nih-gov.ezproxy.cul.columbia.edu/books/NBK525978/.

  38. Swerdlow M. Intrathecal neurolysis. Anaesthesia. 1978;33(8):733–40.

    CAS  PubMed  Google Scholar 

  39. Zafonte RD, Munin MC. Phenol and alcohol blocks for the treatment of spasticity. Phys Med Rehabil Clin N Am. 2001;12:817–32.

    CAS  PubMed  Google Scholar 

  40. Gormley ME Jr, Krach L, Piccini L. Spasticity management in the child with spasticity quadriplegia. Eur J Neurol. 2001;8(Suppl 5):127–35.

    PubMed  Google Scholar 

  41. Morrison JE Jr, Matthews D, Washington R, Fennessey PV, Harrison LM. Phenol motor point blocks in children: plasma concentrations and cardiac dysrythmias. Anesthesiology. 1991;75:359–62.

    PubMed  Google Scholar 

  42. Grigoriu A, Dinomais M, Rémy-Néris O, Brochard S. Impact of injection-guiding techniques on the effectiveness of botulinum toxin for the treatment of focal spasticity and dystonia: a systematic review. Arch Phys Med Rehabil. 2015;96(11):2067–78.

    PubMed  Google Scholar 

  43. Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Ranieri M. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. J Neurol Sci. 2014;347(1–2):39–43.

    CAS  PubMed  Google Scholar 

  44. Irkoren S, Ozkan HS, Karaca H. A clinical comparison of EMLA cream and ethyl chloride spray application for pain relief of forehead botulinum toxin injection. Ann Plast Surg. 2015;75(3):272–4.

    CAS  PubMed  Google Scholar 

  45. Çelik G, Özbek O, Yılmaz M, Duman I, Özbek S, Apiliogullari S. Vapocoolant spray vs lidocaine/prilocaine cream for reducing the pain of venipuncture in hemodialysis patients: a randomized, placebo-controlled, crossover study. Int J Med Sci. 2011;8(7):623–7.

    PubMed  PubMed Central  Google Scholar 

  46. Gupta A, Scott K, Dukewich M. Innovative technology using virtual reality in the treatment of pain: does it reduce pain via distraction, or is there more to it? Pain Med. 2018;19(1):151–9.

    PubMed  Google Scholar 

  47. Aydin D, Sahiner NC. Effects of music therapy and distraction cards on pain relief during phlebotomy in children. Appl Nurs Res. 2017;33:164–8.

    PubMed  Google Scholar 

  48. Alcaraz J, Oliver A, Sanchez JM. Platelet-rich plasma in a patient with cerebral palsy. Am J Case Rep. 2015;16:469–72.

    PubMed  PubMed Central  Google Scholar 

  49. Švehlík M, Steinwender G, Kraus T, Saraph V, Lehmann T, Linhart WE, Zwick EB. The influence of age at single-event multilevel surgery on outcome in children with cerebral palsy who walk with flexed knee gait. Dev Med Child Neurol. 2011;53(8):730–5.

    PubMed  Google Scholar 

  50. Gooch JL, Patton CP. Combining botulinum toxin and phenol to manage spasticity in children. Arch Phys Med Rehabil [Internet]. 2004;85(7):1121–4.

    Google Scholar 

  51. Ploypetch T, Kwon J-Y, Armstrong HF, Kim H. A retrospective review of unintended effects following single-event multi-level chemoneurolysis with botulinum toxin-a and phenol in children with cerebral palsy. PM&R [Internet]. 2015;7(10):1073–80.

    Google Scholar 

  52. Kim H, Lee Y, Weiner D, Kaye R, Cahill AM, Yudkoff M. Botulinum toxin type a injections to salivary glands: combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy. Arch Phys Med Rehabil. 2006;87(1):141–4.

    PubMed  Google Scholar 

  53. Bar-On L, Molenaers G, Aertbeliën E, Van Campenhout A, Feys H, Nuttin B, Desloovere K. Spasticity and its contribution to hypertonia in cerebral palsy. BioMed Res Int. 2015;2015:317047. https://doi.org/10.1155/2015/317047.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Borowski A, Littleton A, Borkhuu B, Presedo A, Shah S, Dabney K, Lyons S, McMannus M, Miller F. Complications of intrathecal baclofen pump therapy in pediatric patients. J Pediatr Orthop. 2010;30(1):76–81.

    PubMed  Google Scholar 

  55. Miller F. Cerebral palsy. New York: Springer Science Business Media; 2005.

    Google Scholar 

  56. Russman BS, Tilton A, Gormley ME. Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment. Muscle Nerve. 1997;20(S6):181–93.

    Google Scholar 

  57. Sala DA, Grant AD, Kummer FJ. Equinus deformity in cerebral palsy: recurrence after tendo achillis lengthening. Dev Med Child Neurol. 1997;39(1):45–8.

    CAS  PubMed  Google Scholar 

  58. Sussman M, Aiona M. Treatment of spastic diplegia in patients with cerebral palsy. J Pediatr Orthop B. 2004;13(2):S12.

    Google Scholar 

  59. Stewart K, Harvey A, Johnston LM. A systematic review of scales to measure dystonia and choreoathetosis in children with dyskinetic cerebral palsy. Dev Med Child Neurol. 2017;59(8):786–95.

    PubMed  Google Scholar 

  60. Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Classification and definition of disorders causing hypertonia in childhood. Pediatrics. 2003;111(1):e89–97.

    PubMed  Google Scholar 

  61. Sanger TD, Chen D, Fehlings DL, et al. Definition and classification of hyperkinetic movements in childhood. Mov Disord. 2010;25:1538–49.

    PubMed  PubMed Central  Google Scholar 

  62. Penn RD, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity. Lancet. 1984;i:1078.

    Google Scholar 

  63. Albright A, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA. 1991;265:1418–22.

    CAS  PubMed  Google Scholar 

  64. Sees JP, Miller F. Intrathecal medication administration in cerebral palsy. (2019) In: Miller F, Bachrach S, Lennon N, O’Neil M (eds) Cerebral palsy, Springer, Cham.

    Google Scholar 

  65. Albright AL, Gilmartin R, Swift D, et al. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg. 2003;98:291–5.

    CAS  PubMed  Google Scholar 

  66. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil. 1996;77:35–9.

    CAS  PubMed  Google Scholar 

  67. Campbell WM, Ferrel A, McLaughlin JF. Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol. 2002;44:660–5.

    PubMed  Google Scholar 

  68. Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russell KD. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia. 1991;29:48–64.

    CAS  PubMed  Google Scholar 

  69. Mathur SN, Chu SK, McCormick Z, Chang-Chien G, Marciniak C. Long-term intrathecal baclofen: outcomes after more than 10 years of treatment. PM&R. 2014;6(6):506–13.

    Google Scholar 

  70. Plassat R, Perrouin Verbe B, Menei P, Menegalli D, Mathe JF, Richard I. Treatment of spasticity with intrathecal baclofen administration: Longterm follow-up, review of 40 patients. Spinal Cord. 2004;42:686–93.

    CAS  PubMed  Google Scholar 

  71. Sadiq SA, Wang GC. Long-term intrathecal baclofen therapy in ambulatory patients with spasticity. J Neurol. 2006;253:563–9.

    CAS  PubMed  Google Scholar 

  72. Winter G, Beni-Adani L, Ben-Pazi H. Intrathecal baclofen therapy—practical approach: clinical benefits and complication management. J Child Neurol. 2018;33(11):734–41.

    PubMed  Google Scholar 

  73. Gilmartin R, Bruce D, Storrs BB, et al. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol. 2000;15:71–7.

    CAS  PubMed  Google Scholar 

  74. Dan B, Motta F, Vles JS. Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity. Eur J Paediatr Neurol. 2010;14:19–28.

    PubMed  Google Scholar 

  75. Hasnat MJ, Rice JE. Intrathecal baclofen for treating spasticity in children with cerebral palsy. Cochrane Database Syst Rev. 2015;11:CD004552. https://doi.org/10.1002/14651858.CD004552.pub2.

    Article  Google Scholar 

  76. Butler C, Campbell S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. Dev Med Child Neurol. 2000;42:634–45.

    CAS  PubMed  Google Scholar 

  77. Blackburn TP, editor. GABAB receptor pharmacology: a tribute to Norman Bowery. 1st ed. San Diego: Academic Press; 2010.

    Google Scholar 

  78. Woon K, Tsegaye M, Vloeberghs MH. The role of intrathecal baclofen in the management of primary and secondary dystonia in children. Br J Neurosurg. 2007;21:355–8.

    CAS  PubMed  Google Scholar 

  79. Medtronic. Synchromed II drug infusion system brief statement. Retrieved July 31, 2019 from: https://www.medtronic.com/us-en/healthcare-professionals/therapies-procedures/neurological/intrathecal-baclofen-therapy.html.

  80. Brashear A, Lambeth K. Spasticity. Curr Treat Options Neurol. 2009;11:153–61.

    PubMed  Google Scholar 

  81. Pin TW, McCartney L, Lewis J, et al. Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review. Dev Med Child Neurol. 2011;53:885–95.

    PubMed  Google Scholar 

  82. Albright AL. Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol. 1996;11(1_suppl):S29–35.

    PubMed  Google Scholar 

  83. Muller H. Treatment of severe spasticity: results of a multi-center trial conducted in Germany involving the intrathecal infusion of baclofen by an implantable drug delivery system. Dev Med Child Neurol. 1992;34:739–45.

    Google Scholar 

  84. Saulino M, Ivanhoe CB, McGuire JR, Ridley B, Shilt JS, Boster AL. Best practices for intrathecal baclofen therapy: patient selection. Neuromodulation. 2016;19(6):607–15.

    PubMed  Google Scholar 

  85. Rifici C, Kofler M, Kronenberg M, Kofler A, Bramanti P, Saltuari L. Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury. Funct Neurol. 1994;9(1):29–34.

    CAS  PubMed  Google Scholar 

  86. Schuele SU, Kellinghaus C, Shook SJ, Boulis N, Bethoux FA, Loddenkemper T. Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology. 2005;64:1086–7.

    CAS  PubMed  Google Scholar 

  87. Zak R, Solomon G, Petito F, Labar D. Baclofen-induced generalized non-convulsive status epilepticus. Ann Neurol. 1994;36:113–4.

    CAS  PubMed  Google Scholar 

  88. Buonaguro V, Scelsa B, Curci D, Monforte S, Iuorno T, Motta F. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy. Pediatr Neurol. 2005;33:110–3.

    PubMed  Google Scholar 

  89. Kofler M, Kronenberg MF, Rifici C, Saltuari L, Bauer G. Epileptic seizures associated with intrathecal baclofen application. Neurology. 1994;44:25–7.

    CAS  PubMed  Google Scholar 

  90. Burn SC, Zeller R, Drake JM. Do baclofen pumps influence the development of scoliosis in children? J Neurosurg Pediatr. 2010;5:195–9.

    PubMed  Google Scholar 

  91. Krach LE, Walker K, Rapp L. The effect of intrathecal baclofen treatment on the development of scoliosis in individuals with cerebral palsy: a retrospective case-matched review. Dev Med Child Neurol. 2005;47:14.

    Google Scholar 

  92. Senaran H, Shah SA, Presedo A, et al. The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy. Spine (Phila Pa 1976). 2007;32:2348–54.

    Google Scholar 

  93. Fulkerson DH, Boaz JC, Luerssen TG. Interaction of ventriculoperitoneal shunt and baclofen pump. Childs Nerv Syst. 2007;23:733–8.

    PubMed  Google Scholar 

  94. Turner MS. Assessing syndromes of catheter malfunction with SynchroMed infusion systems: the value of spiral computed tomography with contrast injection. PM R. 2010;2:757–66.

    PubMed  Google Scholar 

  95. Pucks-Faes E, Matzak H, Hitzenberger G, Genelin E, Halbmayer L, Fava E, Saltuari L. Intrathecal baclofen trial before device implantation: 12-year experience with continuous administration. Arch Phys Med Rehabil. 2019;100(5):837–43.

    PubMed  Google Scholar 

  96. Medtronic. MRI and diagnostic testing compatibility. Retrieved July 31, 2019 from: https://www.medtronic.com/us-en/patients/treatments-therapies/drug-pump-chronic-pain/living-with-therapy/mri.html.

  97. Kopell BH, Sala D, Doyle WK, Feldman DS, Wisoff JH, Weiner HL. Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery. 2001;49:753–7.

    CAS  PubMed  Google Scholar 

  98. Motta F, Antonello CE. Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience. J Neurosurg Pediatr. 2014;13:301–6.

    PubMed  Google Scholar 

  99. Aljuboori Z, Archer J, Huff W, Moreno A, Jea A. Placement of baclofen pump catheter through a C1–2 puncture: technical note. J Neurosurg Pediatr. 2018;21(4):389–94.

    PubMed  Google Scholar 

  100. Albright AL, Ferson SS. Intrathecal baclofen therapy in children. Neurosurg Focus. 2006;21(2):e3.

    PubMed  Google Scholar 

  101. McCall T, MacDonald J. Cervical catheter tip placement for intrathecal baclofen administration. Neurosurgery. 2006;59(3):634–40.

    PubMed  Google Scholar 

  102. Berweck S, Lutjen S, Voss W, et al. Use of intrathecal baclofen in children and adolescents: interdisciplinary consensus table 2013. Neuropediatrics. 2014;45:294–308.

    PubMed  Google Scholar 

  103. Ross JC, Cook AM, Stewart GL, Fahy BG. Acute intrathecal baclofen withdrawal: a brief review of treatment options. Neurocrit Care. 2011;14:103–8.

    PubMed  Google Scholar 

  104. Watve SV, Sivan M, Raza WA, Jamil FF. Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord. 2012;50:107–11.

    CAS  PubMed  Google Scholar 

  105. Stewart K, Hutana G, Kentish M. Intrathecal baclofen therapy in paediatrics: a study protocol for an Australian multicentre, 10-year prospective audit. BMJ Open. 2017;7(6):e015863.

    PubMed  PubMed Central  Google Scholar 

  106. Bayhan IA, Sees JP, Nishnianidze T, Rogers KJ, Miller F. Infection as a complication of intrathecal baclofen treatment in children with cerebral palsy. J Pediatr Orthop. 2016;36(3):305–9.

    PubMed  Google Scholar 

  107. Malheiro L, Gomes A, Barbosa P, Santos L, Sarmento A. Infectious complications of intrathecal drug administration systems for spasticity and chronic pain: 145 patients from a tertiary care center. Neuromodulation. 2015;18(5):421–7.

    PubMed  Google Scholar 

  108. Motta F, Antonello C. Comparison between an Ascenda and a silicone catheter in intrathecal baclofen therapy in pediatric patients: analysis of complications. J Neurosurg Pediatr PED. 2016;18(4):493–8.

    Google Scholar 

  109. Buxton K, Morgan A, Rogers J. Nurse practitioner lead pediatric baclofen pump program: impact on safety and quality of care. J Neurosci Nurs. 2017;49(5):324–9.

    PubMed  Google Scholar 

  110. Fernandes P, Dolan L, Weinstein SL. Intrathecal baclofen withdrawal syndrome following posterior spinal fusion for neuromuscular scoliosis: a case report. Iowa Orthop J. 2008;28:77–80.

    PubMed  PubMed Central  Google Scholar 

  111. Mckinnon W, Lee MC, Kanev P. Mortality from intrathecal baclofen withdrawal following posterior spinal fusion. JBJS Case Connect. 2012;2(3):e32.

    PubMed  Google Scholar 

  112. Caird M, Palanca A, Garton H, Hensinger R, Ayyangar R, Drongowski A, Farley F. Outcomes of posterior spinal fusion and instrumentation in patients with continuous intrathecal baclofen infusion pumps. Spine. 2007;33(4):E94–9.

    Google Scholar 

  113. Gooch JL, Oberg WA, Grams B, et al. Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg. 2003;39:1–6.

    PubMed  Google Scholar 

  114. Boster AL, Bennett SE, Bilsky GS, et al. Best practices for intrathecal baclofen therapy: screening test. Neuromodulation. 2016;19:623–31.

    PubMed  Google Scholar 

  115. Newberg NL, Gooch JL, Walker ML. Intraoperative monitoring in selective dorsal rhizotomy. Pediatr Neurosurg. 1991;17(3):124–7.

    PubMed  Google Scholar 

  116. Kan P, Gooch J, Amini A, et al. Surgical treatment of spasticity in children: comparison of selective dorsal rhizotomy and intrathecal baclofen pump implantation. Childs Nerv Syst. 2008;24(2):239–43.

    PubMed  Google Scholar 

  117. Oki A, Oberg W, Siebert B, Plante D, Walker ML, Gooch JL. Selective dorsal rhizotomy in children with spastic hemiparesis. J Neurosurg Pediatr. 2010;6(4):353–8.

    PubMed  Google Scholar 

  118. Reynolds MR, Ray WZ, Strom RG, Blackburn SL, Lee A, Park TS. Clinical outcomes after selective dorsal rhizotomy in an adult population. World Neurosurg. 2011;75(1):138–44.

    PubMed  Google Scholar 

  119. Tilton AH. Therapeutic interventions for tone abnormalities in cerebral palsy. NeuroRx. 2006;3(2):217–24.

    CAS  PubMed  PubMed Central  Google Scholar 

  120. Tilton A. Management of spasticity in children with cerebral palsy. Semin Pediatr Neurol. 2009;16(2):82–9.

    PubMed  Google Scholar 

  121. Park TS, Gaffney PE, Kaufman BA, Molleston MC. Selective lumbosacral dorsal rhizotomy immediately caudal to the conus medullaris for cerebral palsy spasticity. Neurosurgery. 1993;33(5):929–33.

    CAS  PubMed  Google Scholar 

  122. Steinbok P, Tidemann AJ, Miller S, Mortenson P, Bowen-Roberts T. Electrophysiologically guided versus non-electrophysiologically guided selective dorsal rhizotomy for spastic cerebral palsy: a comparison of outcomes. Child’s Nerv Syst: ChNS. 2009;25(9):1091–6.

    Google Scholar 

  123. Steinbok P, Reiner AM, Beauchamp R, Armstrong RW, Cochrane DD, Kestle J. A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy. Dev Med Child Neurol. 1997;39(3):178–84.

    CAS  PubMed  Google Scholar 

  124. McLaughlin JF, Bjornson KF, Astley SJ, et al. Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol. 1998;40(4):220–32.

    CAS  PubMed  Google Scholar 

  125. McLaughlin J, Bjornson K, Temkin N, et al. Selective dorsal rhizotomy: meta-analysis of three randomized controlled trials. Dev Med Child Neurol. 2002;44(1):17–25.

    PubMed  Google Scholar 

  126. Wright FV, Sheil EM, Drake JM, Wedge JH, Naumann S. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled tria. Dev Med Child Neurol. 1998;40(4):239–47.

    CAS  PubMed  Google Scholar 

  127. Nordmark E, Josenby AL, Lagergren J, Andersson G, Stromblad LG, Westbom L. Long-term outcomes five years after selective dorsal rhizotomy. BMC Pediatr. 2008;8:54.

    PubMed  PubMed Central  Google Scholar 

  128. Gigante P, McDowell MM, Bruce SS, et al. Reduction in upper-extremity tone after lumbar selective dorsal rhizotomy in children with spastic cerebral palsy. J Neurosurg Pediatr. 2013;12:588–94.

    PubMed  Google Scholar 

  129. Engsberg JR, Ross SA, Park TS. Changes in ankle spasticity and strength following selective dorsal rhizotomy and physical therapy for spastic cerebral palsy. J Neurosurg. 1999;91(5):727–32.

    CAS  PubMed  Google Scholar 

  130. Langerak NG, Lamberts RP, Fieggen AG, et al. A prospective gait analysis study in patients with diplegic cerebral palsy 20 years after selective dorsal rhizotomy. J Neurosurg Pediatr. 2008;1(3):180–6.

    PubMed  Google Scholar 

  131. Steinbok P. Outcomes after selective dorsal rhizotomy for spastic cerebral palsy. Childs Nerv Syst. 2001;17(1–2):1–18.

    CAS  PubMed  Google Scholar 

  132. Mittal S, Farmer JP, Al-Atassi B, et al. Impact of selective posterior rhizotomy on fine motor skills. Long-term results using a validated evaluative measure. Pediatr Neurosurg. 2002;36(3):133–41.

    PubMed  Google Scholar 

  133. Ghotbi N, Ansari NN, Naghdi S, Hasson S, Jamshidpour B, Amiri S. Inter-rater reliability of the modified modified Ashworth scale in assessing lower limb muscle spasticity. Brain Inj: [BI]. 2009;23(10):815–9.

    Google Scholar 

  134. Loewen P, Steinbok P, Holsti L, MacKay M. Upper extremity performance and self-care skill changes in children with spastic cerebral palsy following selective posterior rhizotomy. Pediatr Neurosurg. 1998;29(4):191–8.

    CAS  PubMed  Google Scholar 

  135. Ojemann JG, McKinstry RC, Mukherjee P, Park TS, Burton H. Hand somatosensory cortex activity following selective dorsal rhizotomy: report of three cases with fMRI. Childs Nerv Syst. 2005;21(2):115–21.

    PubMed  Google Scholar 

  136. Steinbok P, Schrag C. Complications after selective posterior rhizotomy for spasticity in children with cerebral palsy. Pediatr Neurosurg. 1998;28(6):300–13.

    CAS  PubMed  Google Scholar 

  137. Dudley RW, Parolin M, Gagnon B, et al. Long-term functional benefits of selective dorsal rhizotomy for spastic cerebral palsy. J Neurosurg Pediatr. 2013;12(2):142–50.

    PubMed  Google Scholar 

  138. O’Brien DF, Park TS, Puglisi JA, Collins DR, Leuthardt EC. Effect of selective dorsal rhizotomy on need for orthopedic surgery for spastic quadriplegic cerebral palsy: long-term outcome analysis in relation to age. J Neurosurg. 2004;101(1 Suppl):59–63.

    PubMed  Google Scholar 

  139. Watt JM, Robertson CM, Grace MG. Early prognosis for ambulation of neonatal intensive care survivors with cerebral palsy. Dev Med Child Neurol. 1989;31(6):766–73.

    CAS  PubMed  Google Scholar 

  140. Park TS, Edwards C, Liu JL, Walter DM, Dobbs MD. Beneficial effects of childhood selective dorsal rhizotomy in adulthood. Cureus. 2017;9(3):e1077.

    CAS  PubMed  PubMed Central  Google Scholar 

  141. Gooch JL, Walker ML. Spinal stenosis after total lumbar laminectomy for selective dorsal rhizotomy. Pediatr Neurosurg. 1996;25(1):28–30.

    CAS  PubMed  Google Scholar 

  142. Ravindra VM, Christensen MT, Onwuzulike K, Smith JT, Halvorson K, Brockmeyer DL, Walker ML, Bollo RJ. Risk factors for progressive neuromuscular scoliosis requiring posterior spinal fusion after selective dorsal rhizotomy. J Neurosurg Pediatr. 2017;20(5):456–63.

    PubMed  Google Scholar 

  143. Abdel Ghany WA, Nada M, Mahran MA, Aboud A, Mahran MG, Nasef MA, Gaber M, Sabry T, Ibrahim MH, Taha MH. Combined anterior and posterior lumbar rhizotomy for treatment of mixed dystonia and spasticity in children with cerebral palsy. Neurosurgery. 2016;79(3):336–44.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Physical Medicine and Rehabilitation, Columbia University Irving Medical Center/New York Presbyterian Hospital, New York, NY, USA

    Heakyung Kim & Jared Levin

  2. Division of Pediatric Orthopedic Center for Children, NYU Langone Orthopedic Hospital, New York, NY, USA

    Eduardo Del Rosario & Nicole Bainton

  3. Division of Pediatric Neurosurgery, Columbia University Irving Medical Center, New York, NY, USA

    Richard Anderson

  4. Department of Physical Medicine and Rehabilitation, Pediatric Rehabilitation Medicine, Michigan Medicine, Ann Arbor, MI, USA

    Angeline Bowman

Authors
  1. Heakyung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eduardo Del Rosario
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nicole Bainton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jared Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Angeline Bowman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heakyung Kim .

Editor information

Editors and Affiliations

  1. Department of Orthopedics, Helen DeVos Children’s Hospital, Grand Rapids, MI, USA

    Philip D. Nowicki

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kim, H., Del Rosario, E., Anderson, R., Bainton, N., Levin, J., Bowman, A. (2020). Spasticity Management: Nonoperative and Operative. In: Nowicki, P. (eds) Orthopedic Care of Patients with Cerebral Palsy. Springer, Cham. https://doi.org/10.1007/978-3-030-46574-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-46574-2_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-46573-5

  • Online ISBN: 978-3-030-46574-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation